E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 1, 2008, Pages 258-267

  Yu, Le ^a,b   Wu, William Ka Kei ^a   Li, Zhi Jie ^a,b   Wong, Helen Pui Shan ^a   Tai, Emily Kin Ki ^a   Li, Hai Tao ^a   Wu, Ya Chun ^a   Cho, Chi Hin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BUTAPROST; CURCUMIN; CYCLOOXYGENASE 2; ICOSANOID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR 1; PROSTAGLANDIN RECEPTOR 2; PROSTAGLANDIN RECEPTOR 3; PROSTAGLANDIN RECEPTOR 4; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

ALPROSTADIL; BUTADIENES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGENS; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, PROSTAGLANDIN E; TRANSCRIPTION FACTOR AP-1;

EID: 52649126331     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.141275     Document Type: Article

References (40)

1. Amano H, Hayashi I, Endo H, Kitasato H, Yamashina S, Maruyama T, Kobayashi M, Satoh K, Narita M, Sugimoto Y, et al. (2003) Host prostaglandin E(2)-Ep3 signaling regulates tumor-associate angiogenesis and tumor growth. J Exp Med 197:221-232.
2. Castellone MD, Teramoto H, Williams BO, Druey KM, and Gutkind JS (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310:1504-1510.
3. Chattopadhyay I, Kapur S, Purkayastha J, Phukan R, Kataki A, Mahanta J, and Saxena S (2007) Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis. World J Gastroenterol 13:1438-1444.
4. Cherukuri DP, Chen XB, Goulet AC, Young RN, Han Y, Heimark RL, Regan JW, Meuillet E, and Nelson MA (2007) The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Exp Cell Res 313:2969-2979.
5. Chun KS, Keum YS, Han SS, Song YS, Kim SH, and Surh YJ (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24:1515-1524.
6. Corley DA, Kerlikowske K, Verma R, and Buffler P (2003) Protective association of apirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124:47-56.
7. Donnini S, Finetti F, Solito R, Terzuoli E, Sacchetti A, Morbidelli L, Patrignani P, and Ziche M (2007) EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways. FASEB J 21:2418-2430.
8. Dubios RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, and Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
9. Fulton AM, Ma X, and Kundu N (2006) Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 66:9794-9797.
10. Gerits N, Kostenko S, Shiryaev A, Johannessen M, and Moens U (2008) Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: comradeship and hostility. Cell Signal 20:1592-1607.
11. Guo YS, Hellmich MR, Wen XD, and Townsend CM Jr (2001) Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 276:22941-22947.
12. Gupta RA and DuBois RN (2000) Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer. Ann N Y Acad Sci 910:196-206.
13. Han C and Wu T (2005) Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 280:24053-24063.
14. Han S and Roman J (2004) Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth. Biochem Biophys Res Commun 314:1093-1099.
15. Hu Y, Lam KY, Wan TS, Fang W, Ma ES, Chan LC, and Srivastava G (2000) Establishment of characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet 118:112-120.
16. Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL, Chan LC, Wong J, and Srivastava G (2002) Establishment, characterization, Karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 135:120-127.
17. Jang TJ, Min SK, Bae JD, Jung KH, Lee JI, Kim JR, and Ahn WS (2004) Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 53:27-33.
18. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, and Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
19. Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
20. Kawamori T, Uchiya N, Sugimura T, and Wakabayashi K (2003) Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis 24:985-990.
21. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, and Dubinett SM (2005) Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65:6275-6281.
22. Lau SS, McMahon JB, McMenamin MG, Schuller HM, and Boyd MR (1987) Metabolism of arachidonic acid in human lung cancer cell lines. Cancer Res 47:3757-3762.
23. Leng J, Han C, Demetris AJ, Michalopoulos GK, and Wu T (2003) Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38:756-768.
24. Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC, and Cheung AL (2007) ID-1 activation of PI3K/Akt/NfkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28:2313-2320.
25. Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK, et al. (2002) Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 21:7680-7689.
26. Morgan G (1997) Deleterious effects of Prostaglandin E2 in oesophageal carcinogenesis. Med Hypotheses 48:177-181.
27. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, Tani K, Kobayashi M, Maruyama T, Kobayashi K, et al. (2002) Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 62:28-32.
28. Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Narumiya S, and Taketo MM (2002) Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in APC(Delta716) mouse intestinal polyps. Cancer Res 62:506-511.
29. Shaulian E and Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136.
30. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, and Taketo MM (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC(Delta 716) knockout mice. Nat Med 7:1048-1051.
31. Souza RF (2002) Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg Oncol Clin N Am 11:257-272.
32. Stoner GD, Qin H, Chen T, Carlton PS, Rose ME, Aziz RM, and Dixit R (2005) The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 26:1590-1595.
33. Stoner GD, Wang LS, and Chen T (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 224:337-349.
34. Vanchieri C (2004) Vioxx withdrawal alarms cancer prevention researchers. J Natl Cancer Inst 96:1734-1735.
35. Wang D, Wang H, Shi Q, Katkuri S, Walhi W, Desvergne B, Das SK, Dey Sk, and DuBoid RN (2004) Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell 6:285-295.
36. Wang D, Wang M, Cheng Y, and Fitzgerald GA (2005) Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Curr Opin Pharmacol 5:204-210.
37. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Ushikubi F, Narumiya S, et al. (1999) Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res 59:5093-5096.
38. Young MR, Yang HS, and Colburn NH (2003) Promising molecular targets for cancer prevention: AP-1, NF-kappaB and Pdcd4. Trends Mol Med 9:36-41.
39. Zhi H, Wang L, Zhang J, Zhou C, Ding F, Luo A, Wu M, Zhan Q, and Liu Z (2006) Significance of COX-2 expression in human esophageal squamous cell carcinoma. Carcinogenesis 27:1214-1221.
40. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, and Schrör K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198-204.